| Literature DB >> 25203427 |
Justin M M Cates1, K Ashley Troutman.
Abstract
Governmental regulations and most published guidelines do not provide specific guidance on implementation of quality management (QM) programs for immunohistochemistry (IHC) assays in Anatomic Pathology. QM of IHC consists of 3 main components: quality control, quality assurance, and quality improvement initiatives, each entailing distinctive but interrelated objectives. Discussion of the principles and some specific practices involved in these phases of QM of the IHC laboratory are therefore offered in this review, with an admitted emphasis on pragmatism.Mesh:
Year: 2015 PMID: 25203427 DOI: 10.1097/PAI.0000000000000111
Source DB: PubMed Journal: Appl Immunohistochem Mol Morphol ISSN: 1533-4058